New pill helps obese adults shed pounds in 26-Week trial
NCT ID NCT06841445
First seen Apr 14, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tested a new tablet called HRS9531 in 166 adults with obesity (BMI 28-40). Participants took the tablet or a placebo for 26 weeks to see how much weight they lost. The goal was to find a safe and effective way to help manage body weight over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MANAGEMENT OF BODY WEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Drum Tower hospital
Nanjing, Jiangsu, 210008, China
Conditions
Explore the condition pages connected to this study.